INTEGRATING BIOINFORMATICS TOOLS; MOLECULAR SCREENING FOR DRUG DISCOVERY AGAINST ESTROGEN POSITIVE BREAST CANCER

Main Article Content

Eimen Rasool
Rimsha Anwaar
Arshha Naeem
Azka Razzaq
Sheeza Shoukat
Bushra Hameed
Muhammad Akhtar Abbas
Azhar Shabbir

Keywords

.

Abstract

Breast cancer is the most devastating malignancy affecting women globally. Although effective treatment options are available, many of these drugs can cause severe side effects and may be ineffective in some patients, leading to limited therapeutic outcomes. This study aims to identify potent bioactive compounds through extensive screening of various phytochemicals using bioinformatics techniques to develop a promising therapeutic strategy for estrogen positive breast cancer. The study utilized breast cancer-related estrogen protein and analyzed Nigella sativa phytochemicals with established anticancer properties based on their pathophysiological relevance, pharmacokinetics, and drug-like characteristics using the SwissAdme web server. After conducting molecular docking with p, the top six ligands for protein were identified. The selected compounds were further evaluated for bioavailability and toxicity using SwissAdme and ADMETSAR to ensure their potential as viable therapeutic candidates. The initial screening of 60 phytochemicals identified 9 compounds that complied with the Lipinski rule. Based on their binding affinity scores, the top six molecules were selected, leading to a shortlist of 6 potential drug candidates. These compounds Thymoquinone, Gallic acid, Apigenin, Luteolin, Patuletin and Myricetin were found to be safe and non-toxic. The findings contribute to advancing traditional medicine-based therapies and identifying potential candidates for lead optimization in breast cancer treatment. These results can be validated through molecular dynamics simulations and experimental studies using animal models, paving the way for the development of targeted breast cancer therapies.

Abstract 162 | pdf Downloads 55

References

1. Shen, S., S. Vagner, and C. Robert, Persistent cancer cells: the deadly survivors. Cell, 2020. 183(4): p. 860-874.
2. Zaib, S., et al., Fabrication and evaluation of anticancer potential of diosgenin incorporated chitosan-silver nanoparticles; in vitro, in silico and in vivo studies. International Journal of Biological Macromolecules, 2024. 254: p. 127975.
3. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2018. CA: a cancer journal for clinicians, 2018. 68(1): p. 7-30.
4. Smolarz, B., A.Z. Nowak, and H. Romanowicz, Breast cancer—epidemiology, classification, pathogenesis and treatment (review of literature). Cancers, 2022. 14(10): p. 2569.
5. Zahra, N., et al., In-vivo and in-silico analysis of anti-inflammatory, analgesic, and anti pyretic activities of in-silico leaf extract. Journal of the Chilean Chemical Society, 2023. 68(2): p. 5813-5821.
6. Newman, D.J. and G.M. Cragg, Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of natural products, 2020. 83(3): p. 770-803.
7. Gaikwad, S. and S.K. Srivastava, Role of phytochemicals in perturbation of redox homeostasis in cancer. Antioxidants, 2021. 10(1): p. 83.
8. Gholipour, A.R., et al., Apoptosis Effects of Oxalis corniculata L. Extract on Human MCF-7 Breast Cancer Cell Line. Galen Medical Journal, 2022. 11: p. e2484.
9. Sultan, M.T., et al., Nigella sativa fixed and essential oil improves antioxidant status through modulation of antioxidant enzymes and immunity. Pakistan journal of pharmaceutical sciences, 2015. 28(2): p. 589-596.
10. Shafi, G., et al., Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa. Cancer Cell International, 2009. 9: p. 1-8.
11. Li, K., et al., Bioinformatics approaches for anti-cancer drug discovery. Current drug targets, 2020. 21(1): p. 3-17.
12. Ravichandran, R. and R. Sundararajan, In silico-based virtual drug screening and molecular docking analysis of phytochemical derived compounds and FDA approved drugs against BRCA1 receptor. J. Cancer Prev. Curr. Res, 2017. 8: p. 00268-00275.
13. Acharya, R., et al., Structure based multitargeted molecular docking analysis of selected furanocoumarins against breast cancer. Scientific reports, 2019. 9(1): p. 15743.
14. Molinspiration, C.J.h.w.m.c.c.-b.p., Calculation of molecular properties and bioactivity score. 2011.
15. Lipinski, C.A., et al., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. 2012. 64: p. 4-17.
16. Arif, R., et al., Molecular docking and simulation studies of antidiabetic agents devised from hypoglycemic polypeptide-P of Momordica charantia. BioMed research international, 2021. 2021.
17. Ali, M., et al., Screening of Multitarget Compounds against Acetaminophen Hepatic Toxicity Using In Silico, In Vitro, and In Vivo Approaches. Molecules, 2024. 29(2): p. 428.
18. Trott, O. and A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry, 2010. 31(2): p. 455-461.
19. Liu, K., et al., Identification of a novel farnesoid X receptor agonist, kaempferol-7-O-rhamnoside, a compound ameliorating drug-induced liver injury based on virtual screening and in vitro validation. 2022. 454: p. 116251.
20. Cai, F.-F., et al., Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomedicine & Pharmacotherapy, 2019. 114: p. 108863.
21. Lim, E., et al., Pushing estrogen receptor around in breast cancer. Endocrine-related cancer, 2016. 23(12): p. T227-T241.
22. Oselusi, S.O., A. Christoffels, and S.A. Egieyeh, Cheminformatic characterization of natural antimicrobial products for the development of new lead compounds. Molecules, 2021. 26(13): p. 3970.
23. Akinyede, K.A., et al., In vitro evaluation of the anti-diabetic potential of aqueous acetone helichrysum petiolare extract (AAHPE) with molecular docking relevance in diabetes mellitus. Molecules, 2021. 27(1): p. 155.
24. Zhang, X., et al., Network pharmacology based virtual screening of active constituents of Prunella vulgaris L. and the molecular mechanism against breast cancer. Scientific reports, 2020. 10(1): p. 15730.